<--- Back to Details
First PageDocument Content
Substance abuse / Morphinans / Euphoriants / Substance dependence / Psychiatric diagnosis / Drug overdose / Opioid use disorder / Opioid / Naloxone / Drug rehabilitation / Buprenorphine / Heroin
Date: 2012-03-08 14:12:07
Substance abuse
Morphinans
Euphoriants
Substance dependence
Psychiatric diagnosis
Drug overdose
Opioid use disorder
Opioid
Naloxone
Drug rehabilitation
Buprenorphine
Heroin

Recommendations Prevention of Misuse and Abuse of Prescription Drugs Prevention of Deaths from Unintentional Prescription Drug Overdoses Developed by the Prescription Drug Abuse Action Group April 5, 2010

Add to Reading List

Source URL: www.healthy.ohio.gov

Download Document from Source Website

File Size: 322,80 KB

Share Document on Facebook

Similar Documents

Microsoft Word - VLD Packet.FINAL

Microsoft Word - VLD Packet.FINAL

DocID: 1rubZ - View Document

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

DocID: 1rtjz - View Document

TITAN	PHARMACEUTICALS	  CORPORATE	PRESENTATION	Ÿ	SUNIL	BHONSLE	Ÿ	JUNE	2016 ©	2016	TITAN	PHARMACEUTICALS	INC.	Ÿ	NASDAQ:TTNP

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

DocID: 1rsmr - View Document

Sunil Bhonsle  Mar 2015 Corporate Presentation

Sunil Bhonsle Mar 2015 Corporate Presentation

DocID: 1rrwl - View Document

Adapt v13_doc revised

Adapt v13_doc revised

DocID: 1rrqr - View Document